Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
EFSA Journal. European Food Safety Authority|July 23, 2024
New developments in biotechnology applied to microorganisms, Ewen Mullins, Jean-Louis Bresson, et al.
The Lancet. Neurology|February 15, 2020
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational studyThaís Armangue, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 TrialRobert J Motzer, Axel Bex, Paul Russo, et al.
Acta Neuropathologica Communications|August 17, 2022
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion diseaseEllen Gelpi, Simone Baiardi, Carlos Nos, et al.
British Journal of Cancer|October 16, 2018
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosisLuis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|February 14, 2026
Vagus nerve stimulation for drug-resistant epilepsy and predictors for seizure freedom: A nationwide multicenter cohort study in MexicoMaría F Castelo-Pablos, Alma M Huerta-Hurtado, Immer Armendáriz-Betancourt, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
International Archives of Allergy and Immunology|August 15, 2021
Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic PatientsSantiago Nevot-Falcó, Eloina Gonzalez Mancebo, Antonio Martorell, et al.
United European Gastroenterology Journal|August 2, 2024
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countriesPatricio Medel-Jara, Diego Reyes Placencia, Eduardo Fuentes-López, et al.
Pageof 32